I. Kirsch

发表

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

K. Davis, Y. Natkunam, M. Ozawa, 2021, Nature Medicine.

Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials

H. Kohrt, J. Wolchok, L. Zitvogel, 2016, Journal of Immunotherapy for Cancer.

Immunotherapy biomarkers 2016: overcoming the barriers

J. Berzofsky, B. Seliger, B. Fox, 2017, Journal of Immunotherapy for Cancer.

Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations

K. Dobbin, L. Butterfield, S. Selvan, 2016, Journal of Immunotherapy for Cancer.

Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation

K. Dobbin, L. Butterfield, S. Selvan, 2016, Journal of Immunotherapy for Cancer.

Immune monitoring technology primer: immunosequencing

I. Kirsch, 2015, Journal of Immunotherapy for Cancer.

T‐cell receptor profiling in cancer

M. Vignali, H. Robins, Marissa Vignali, 2015, Molecular oncology.

Diagnosis and Tracking of SARS-CoV-2 Infection By T-Cell Receptor Sequencing

E. Lavezzo, S. Toppo, G. Tonon, 2020 .

The Immune Phenotype of Isolated Lymphoid Structures in Non-Tumorous Colon Mucosa Encrypts the Information on Pathobiology of Metastatic Colorectal Cancer

P. Zimmermann, M. Jaritz, T. Gruenberger, 2020, Cancers.